Valley National Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-478
Closed -$33K 1209
2024
Q1
$33K Sell
478
-125
-21% -$7.91K 0.01% 463
2023
Q4
$44K Sell
603
-170
-22% -$11.1K 0.01% 419
2023
Q3
$53K Buy
773
+176
+29% +$14.9K 0.01% 378
2023
Q2
$57K Sell
597
-40
-6% -$3.12K 0.01% 372
2023
Q1
$42K Buy
637
+363
+132% +$23.3K 0.01% 408
2022
Q4
$18K Buy
274
+153
+126% +$6.25K ﹤0.01% 504
2022
Q3
$4K Buy
121
+31
+34% +$1.28K ﹤0.01% 705
2022
Q2
$4K Buy
90
+7
+8% +$374 ﹤0.01% 690
2022
Q1
$6K Buy
83
+39
+89% +$2.85K ﹤0.01% 674
2021
Q4
$3K Hold
44
﹤0.01% 740
2021
Q3
$4K Buy
44
+8
+22% +$845 ﹤0.01% 695
2021
Q2
$4K Buy
36
+2
+6% +$239 ﹤0.01% 700
2021
Q1
$4K Buy
+34
New +$4.65K ﹤0.01% 651

Other funds holding EXAS

Valley National Advisers's EXAS Position: Q2 2024 in Review

Valley National Advisers sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 478 shares — an estimated $33K sold.

Valley National Advisers first reported a position in EXAS in Q1 2021 and held it in 13 quarters. The position peaked at $57K in Q2 2023. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Valley National Advisers reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Valley National Advisers sold 478 Exact Sciences shares in Q2 2024, an estimated $33K.
  • Valley National Advisers first reported a position in Exact Sciences in Q1 2021 and held it in 13 quarters.
  • Valley National Advisers's Exact Sciences position peaked at $57K in Q2 2023.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Valley National Advisers's 13F filing for Q2 2024, filed 18 Jul 2024.